Cargando…
Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232390/ https://www.ncbi.nlm.nih.gov/pubmed/35637251 http://dx.doi.org/10.1038/s41388-022-02354-2 |
| _version_ | 1784735570289754112 |
|---|---|
| author | Georgiou, Marina Ntavelou, Panagiota Stokes, William Roy, Rajat Maher, Geoffrey J. Stoilova, Tsvetana Choo, Josephine A.M.Y. Rakhit, Callum P. Martins, Miguel Ajuh, Paul Horowitz, Neil Berkowitz, Ross S. Elias, Kevin Seckl, Michael J. Pardo, Olivier E. |
| author_facet | Georgiou, Marina Ntavelou, Panagiota Stokes, William Roy, Rajat Maher, Geoffrey J. Stoilova, Tsvetana Choo, Josephine A.M.Y. Rakhit, Callum P. Martins, Miguel Ajuh, Paul Horowitz, Neil Berkowitz, Ross S. Elias, Kevin Seckl, Michael J. Pardo, Olivier E. |
| author_sort | Georgiou, Marina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232390 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92323902022-06-26 Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma Georgiou, Marina Ntavelou, Panagiota Stokes, William Roy, Rajat Maher, Geoffrey J. Stoilova, Tsvetana Choo, Josephine A.M.Y. Rakhit, Callum P. Martins, Miguel Ajuh, Paul Horowitz, Neil Berkowitz, Ross S. Elias, Kevin Seckl, Michael J. Pardo, Olivier E. Oncogene Correction Nature Publishing Group UK 2022-05-30 2022 /pmc/articles/PMC9232390/ /pubmed/35637251 http://dx.doi.org/10.1038/s41388-022-02354-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Georgiou, Marina Ntavelou, Panagiota Stokes, William Roy, Rajat Maher, Geoffrey J. Stoilova, Tsvetana Choo, Josephine A.M.Y. Rakhit, Callum P. Martins, Miguel Ajuh, Paul Horowitz, Neil Berkowitz, Ross S. Elias, Kevin Seckl, Michael J. Pardo, Olivier E. Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title | Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title_full | Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title_fullStr | Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title_full_unstemmed | Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title_short | Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| title_sort | correction: atr and cdk4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232390/ https://www.ncbi.nlm.nih.gov/pubmed/35637251 http://dx.doi.org/10.1038/s41388-022-02354-2 |
| work_keys_str_mv | AT georgioumarina correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT ntaveloupanagiota correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT stokeswilliam correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT royrajat correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT mahergeoffreyj correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT stoilovatsvetana correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT choojosephineamy correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT rakhitcallump correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT martinsmiguel correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT ajuhpaul correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT horowitzneil correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT berkowitzrosss correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT eliaskevin correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT secklmichaelj correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma AT pardooliviere correctionatrandcdk46inhibitiontargetthegrowthofmethotrexateresistantchoriocarcinoma |